Neurodegenerative Diseases

The primary causes are not well defined for most neurodegenerative diseases. The grounding supports a genetic basis in some familial cases, and also indicates that inheritance and susceptibility genes contribute to disease risk in disorders such as Alzheimer’s disease. Other implicated contributors include aging and disturbances in cellular homeostasis, but the supplied material does not support a single unified cause.

The literature describes neurodegeneration as involving mixed proteinopathy, protein aggregation, neuroinflammation, oxidative stress, autophagy dysfunction, apoptosis, endoplasmic reticulum stress, altered energy metabolism, and disrupted signal transduction. Specific proteins and processes repeatedly studied include amyloid beta-peptides, tau, alpha-synuclein, cytokines, microRNAs, and neurotrophic factors, along with microglial and astrocytic activation. Blood-brain barrier dysfunction and exosome-mediated intercellular signaling are also implicated in disease mechanisms.

Aging is a supported risk factor in the supplied grounding. Genetic mutations and inherited susceptibility also increase risk, particularly for familial forms of Alzheimer’s disease and other monogenic neurological disorders linked to neurodegeneration. The literature additionally associates neurodegenerative disease with blood-brain barrier breakdown and broader disturbances in CNS homeostasis, but the grounding does not support more specific risk factors.

The supplied grounding does not support a single standard-of-care treatment for neurodegenerative diseases as a group. It indicates that effective disease-modifying therapies are lacking for most patients, especially in Alzheimer’s disease. The literature focus includes drug therapy and therapy at a broad level, but no specific treatment classes are supported strongly enough here to summarize as standard care.